anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Investor Day Presentation Deck | 43 slides

43 pages · 5 arc beats · 0 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Investor Day Presentation Deck | 43 slides

AstraZeneca · 2022-06
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Key Performance Indicators Overview 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Key Takeaways 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Roadmap 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides

Slide inventory

43
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
transition
Open slide detail
04
introduce_nominees
Open slide detail
05
front_matter
Open slide detail
06
The slide uses a four-column layout to categorize strategic pillars. The bottom right chart illustrates Loss of Exclusivity (LoE) timelines for key drugs.summarize
Open slide detail
07
The slide highlights a 4-year trend of plenary presentations and specific drug trial updates.summarize
Open slide detailBeat · Key Performance Indicators Overview
08
Includes a headshot of Susan Galbraith and a stylized illustration of a drug molecule/mechanism.transition
Open slide detail
09
The slide uses a biological process diagram to explain the drug's mechanism and a list to categorize clinical milestones.present_solution
Open slide detail
10
The slide uses a matrix-like layout to map treatment lines against cancer types, emphasizing the 'replace' strategy in existing markets and 'broaden/expand' strplan_implementation
Open slide detailBeat · Roadmap
11
The slide uses a donut chart to represent the distribution of HER2 expression levels in breast cancer patients.present_framework
Open slide detail
12
Waterfall plot shows N=50. Spider plot shows longitudinal response over weeks.analyze_data
Open slide detail
13
Includes AstraZeneca branding and a medical illustration of an antibody-drug conjugate.transition
Open slide detail
14
The slide uses a standard clinical trial flow diagram (randomization process).present_framework
Open slide detail
15
Includes highlighted rows for HER2 status, Hormone receptor status, and metastatic sites.analyze_data
Open slide detail
16
The table highlights median lines of therapy and specific categories of prior treatment exposure.analyze_data
Open slide detail
17
Clinical trial data presentation showing mPFS and Hazard Ratios.analyze_data
Open slide detail
18
Includes hazard ratios, confidence intervals, p-values, and median overall survival (mOS) for each cohort.analyze_data
Open slide detail
19
The slide uses a forest plot to visualize hazard ratios with 95% confidence intervals for multiple clinical subgroups.analyze_data
Open slide detail
20
Includes detailed footnotes defining abbreviations and study parameters.analyze_data
Open slide detail
21
Includes clinical trial data for DESTINY-Breast04.summarize
Open slide detailBeat · Key Takeaways
22
transition
Open slide detail
23
The slide uses a chronological sequence of Kaplan-Meier survival curves to show the evolution of the drug's efficacy across different patient lines.illustrate_case
Open slide detail
24
The chart is a stacked bar chart illustrating the composition of breast cancer subtypes.diagnose_problem
Open slide detailBeat · Problem
25
The slide uses a horizontal bar chart format to compare treatment durations across different lines of therapy (2L+, 3L+, 4L+).compare_peers
Open slide detail
26
The chart uses a stacked bar approach to illustrate market penetration and clinical trial coverage (DESTINY-Breast04/06) across treatment lines.present_solution
Open slide detailBeat · Solution
27
transition
Open slide detail
28
The slide contrasts clinical efficacy data (waterfall plot) with a clinical trial design schematic.present_solution
Open slide detail
29
The slide uses a complex matrix layout to map patient segments (rows) against treatment lines (columns).present_solution
Open slide detail
30
The slide uses a matrix-like layout to show standard of care vs. clinical trial intervention points.plan_implementation
Open slide detail
31
The slide presents clinical trial data (Kaplan-Meier curve and summary table) and a trial design flowchart.analyze_data
Open slide detail
32
Includes AACR 2022 conference branding.analyze_data
Open slide detail
33
Includes a spider plot (left) and a waterfall plot (right) to demonstrate efficacy.analyze_data
Open slide detail
34
Includes waterfall plot and spider plots for clinical trial data.analyze_data
Open slide detail
35
The slide uses Kaplan-Meier survival curves to demonstrate clinical efficacy.analyze_data
Open slide detail
36
transition
Open slide detail
37
introduce_nominees
Open slide detail
38
appendix
Open slide detail
39
transition
Open slide detail
40
The slide presents clinical trial data comparing T-DXd against TPC in two patient cohorts (HR+ and HR-).analyze_data
Open slide detail
41
Waterfall plot showing individual patient responses; asterisks denote HR-negative disease.analyze_data
Open slide detail
42
introduce_nominees
Open slide detail
43
front_matter
Open slide detail